Send a Tweet
Most Popular Choices
Share on Facebook 9 Share on Twitter Printer Friendly Page More Sharing
OpEdNews Op Eds    H3'ed 5/20/20

Harvard Doctor: As States Rush to Reopen, Lack of COVID-19 Testing Is "Achilles Heel" for U.S.

By       (Page 1 of 5 pages) (View How Many People Read This)   No comments
Author 84160
Message Democracy Now

See original here

President Trump claimed Monday he's been taking the antimalarial drug hydroxychloroquine, even though multiple studies show the drug can be dangerous and is not an effective treatment for COVID-19. This comes as the U.S. COVID-19 death count tops 90,000 and all 50 U.S. states prepare to partially reopen by Memorial Day. We speak with Dr. Ashish Jha, the director of Harvard University's Global Health Institute, who says that testing needs to vastly improve in order for widespread reopenings. He calls the lack of accurate tests in the U.S. the nation's "Achilles heel," saying, "The testing saga will go down as one of the big fiascos that led to us being where we are today."

Transcript

This is a rush transcript. Copy may not be in its final form.

AMY GOODMAN: This is Democracy Now!, democracynow.org, The Quarantine Report. I'm Amy Goodman, here in New York City. Juan Gonza'lez is joining us from his home in New Jersey. As the COVID-19 death toll tops 90,000 in the United States, President Trump claimed Monday he's been taking the antimalarial drug hydroxychloroquine, even though multiple studies show the drug can be dangerous, is not effective in treating COVID-19.

PRESIDENT DONALD TRUMP: Good things have come out about the hydroxy. A lot of good things have come out. And you'd be surprised at how many people are taking it, especially the frontline workers, before you catch it. The frontline workers, many, many are taking it. I happen to be taking it. I happen to be taking it.

REPORTER 1: Hydroxychloroquine?

PRESIDENT DONALD TRUMP: I'm taking it, hydroxychloroquine.

REPORTER 2: Right now?

REPORTER 3: When?

PRESIDENT DONALD TRUMP: Right now, yeah.

REPORTER 3: Yeah, when?

Next Page  1  |  2  |  3  |  4  |  5

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

 

Rate It | View Ratings

Democracy Now Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Democracy Now!  is a national, daily, independent, award-winning news program hosted by journalists Amy Goodman and Juan Gonzalez. Pioneering the largest public media collaboration in the U.S., Democracy Now! is broadcast on (more...)
 
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

After Trip to Gaza, Anthony Bourdain Accused World of Robbing Palestinians of Their Basic Humanity

Glenn Greenwald: Why the Obama Administration's Persecution of Bradley Manning Should Terrify Us All

Julian Assange on WikiLeaks, Bradley Manning, Cypherpunks, Surveillance State, from DemocracyNow

Bernie Sanders on Resisting Trump, Why the Democratic Party is an "Absolute Failure" & More

Seymour Hersh: Obama "Cherry-Picked" Intelligence on Syrian Chemical Attack to Justify U.S. Strike

Seymour Hersh Details Explosive Story on Bin Laden Killing & Responds to White House, Media Backlash

To View Comments or Join the Conversation: